BEIJING BOHUI INNOVATION BIOTECHNOLOGY GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.94 CNY | -0.80% |
|
-0.40% | -20.83% |
Beijing Bohui Innovation Biotechnology Group Co Ltd, formerly Beijing Bohui Innovation Biotechnology Co Ltd is a China-based company mainly engaged in testing and biological products. The testing business products are divided into testing instruments and testing reagents, including human papillomavirus (HPV) testing products, trace element testing products, mass spectrometry related testing products, and others. The biological products mainly cover three categories: albumin, immunoglobulin and human coagulation factors, including human serum albumin, human immunoglobulin, intravenous human immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, human prothrombin complex, and others. The Company mainly operates its business in the domestic market.
Sector
Pharmaceuticals
Calendar
2024-08-27
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -20.83% | 555M | |
| +3.79% | 95.71B | |
| +6.58% | 41.64B | |
| -13.20% | 32.7B | |
| +78.39% | 28.65B | |
| -16.02% | 15.38B | |
| -8.17% | 12.97B | |
| -12.49% | 11.47B | |
| +162.44% | 9.92B | |
| -54.92% | 9.07B |
- Stock Market
- Equities
- 300318 Stock
- News Beijing Bohui Innovation Biotechnology Group Co., Ltd.
- Bohui Innovation Biotech Unit Gets Operation Permit for Plasma Center
